Showing 51 - 60 of 364,188
Objective: To study how changes in insurance benefit design affect medication use of older adults with mental disorders.Data sources: US Medicare claims data from 2007 to 2018.Study Design: We focus on the gradual elimination of the Medicare prescription drug coverage gap beginning in 2011, and...
Persistent link: https://www.econbiz.de/10012549072
There is much debate about whether the Medicare Prescription Drug Bill -- the greatest expansion of Medicare benefits since its creation in 1965 -- will improve the health of elderly Americans, and how much it will cost. We model how insurance affects medical care utilization, and subsequently,...
Persistent link: https://www.econbiz.de/10013223173
The highly uneven distribution of Medicare payments among elderly beneficiaries, combined with the predictability of some of the expenditures, poses several challenges to the Medicare program. We present information about the distribution of Medicare expenditures among beneficiaries in specific...
Persistent link: https://www.econbiz.de/10013249555
Persistent link: https://www.econbiz.de/10013253190
Persistent link: https://www.econbiz.de/10013279421
Persistent link: https://www.econbiz.de/10012665332
In the last two decades, Medicare spending has doubled in real terms despite the fact that the health of Medicare beneficiaries improved over this period. The goals of this paper are to document how trends in spending by age have changed among elderly Medicare beneficiaries in the last decade...
Persistent link: https://www.econbiz.de/10013313646
We examine the impact of the expansion of public prescription drug insurance coverage from Medicare Part D on the elderly and find evidence of substantial crowd-out. Using detailed data from the 2002-7 waves of the Medical Expenditure Panel Survey (MEPS), we estimate that the extension of Part D...
Persistent link: https://www.econbiz.de/10012462502
This paper constructs a rich model of saving for retired single people. Our framework allows for bequest motives and heterogeneity in medical expenses and life expectancies. We estimate the model using AHEAD data and the method of simulated moments. The data show that out-of-pocket medical...
Persistent link: https://www.econbiz.de/10012463501
Features of Part D gave rise to broad concern that the drug benefit would negatively impact prescription utilization among the six million dual eligible beneficiaries, either during the transition from state Medicaid to Part D coverage, or in the long-run. At the same time, Part D contained...
Persistent link: https://www.econbiz.de/10012464234